| Sıra No | Açıklama | Birimi | Brans Kodu | Miktarı |
|---|---|---|---|---|
| 1 | 3-3 DİAMİNOBENZİDİN | GRAM | YARDIMCI SARF MALZEMELER | 2 |
| 2 | 4-METHLY 2-PENTANON | LİTRE | YARDIMCI SARF MALZEMELER | 2 |
| 3 | ACİD FUCHSİN | GRAM | YARDIMCI SARF MALZEMELER | 5 |
| 4 | ADENOZİN 5 FOSFAT | GRAM | YARDIMCI SARF MALZEMELER | 2 |
| 5 | ALCİAN BLUE | GRAM | YARDIMCI SARF MALZEMELER | 5 |
| 6 | AMONYUM OKSALAT | GRAM | YARDIMCI SARF MALZEMELER | 2 |
| 7 | ANİLİNE BLUE | GRAM | YARDIMCI SARF MALZEMELER | 10 |
| 8 | B-NİCOTİNAMİDE ADENİNE DİNUCLEATİDE | GRAM | YARDIMCI SARF MALZEMELER | 50 |
| 9 | CALCİUM CHLORİDE | GRAM | YARDIMCI SARF MALZEMELER | 50 |
| 10 | CARBON FUCHSİN | GRAM | YARDIMCI SARF MALZEMELER | 10 |
| 11 | CATALAZ | GRAM | Klinik kimya kalibratörü, çoklu bileşen | 2 |
| 12 | CYTOCROM-C | GRAM | Klinik kimya kalibratörü, tek bileşenli | 5 |
| 13 | DOKU GÖMME MATRİKSİ | ADET | Kimyasal Yapıştırıcılar | 15 |
| 14 | DOKU İŞARETLEME BOYASI | SET | YARDIMCI SARF MALZEMELER | 2 |
| 15 | DOKU TAKİP KASETİ | ADET | YARDIMCI SARF MALZEMELER | 10.000 |
| 16 | EA-50 | LİTRE | SOLÜSYONLAR, "Belirtin" | 60 |
| 17 | EOSİN Y SOLÜSYONU | LİTRE | SOLÜSYONLAR, "Belirtin" | 50 |
| 18 | FAST GREEN FCR | GRAM | Klinik kimya kalibratörü, tek bileşenli | 50 |
| 19 | FORMALİN | LİTRE | Sabitleyici, formalin | 500 |
| 20 | GİEMSA | LİTRE | Boya, ışık mikroskopisi, sitoloji/histoloji | 5 |
| 21 | GLİKOJEN | GRAM | SOLÜSYONLAR, "Belirtin" | 12 |
| 22 | GLİKOZ 1-FOSFAT | GRAM | SOLÜSYONLAR, "Belirtin" | 5 |
| 23 | GLYCEROL | LİTRE | SOLÜSYONLAR, "Belirtin" | 5 |
| 24 | GOLD (III) CHLORİDE TRİHYDRATE | GRAM | YARDIMCI SARF MALZEMELER | 5 |
| 25 | GUM MASTİK | GRAM | Klinik kimya kalibratörü, çoklu bileşen | 25 |
| 26 | HEMATOKSİLEN HARRİS | LİTRE | SOLÜSYONLAR, "Belirtin" | 50 |
| 27 | İMMÜNFLORESAN PRİMER ANTİKOR (C 1Q) | TEST | İnsan anti-fare antikor kiti | 200 |
| 28 | İMMÜNFLORESAN PRİMER ANTİKOR (C3) | TEST | İnsan anti-fare antikor kiti | 200 |
| 29 | İMMÜNFLORESAN PRİMER ANTİKOR (C4d) | TEST | İnsan anti-fare antikor kiti | 200 |
| 30 | İMMÜNFLORESAN PRİMER ANTİKOR (DİSFERLİN) | TEST | İnsan anti-fare antikor kiti | 25 |
| 31 | İMMÜNFLORESAN PRİMER ANTİKOR (DİSTROGLİKAN) | TEST | İnsan anti-fare antikor kiti | 25 |
| 32 | İMMÜNFLORESAN PRİMER ANTİKOR (DYS1) | TEST | İnsan anti-fare antikor kiti | 25 |
| 33 | İMMÜNFLORESAN PRİMER ANTİKOR (DYS2) | TEST | İnsan anti-fare antikor kiti | 25 |
| 34 | İMMÜNFLORESAN PRİMER ANTİKOR (DYS3) | TEST | İnsan anti-fare antikor kiti | 25 |
| 35 | İMMÜNFLORESAN PRİMER ANTİKOR (FİBRİNOJEN) | TEST | İnsan anti-fare antikor kiti | 50 |
| 36 | İMMÜNFLORESAN PRİMER ANTİKOR (IG A) | TEST | İnsan anti-fare antikor kiti | 200 |
| 37 | İMMÜNFLORESAN PRİMER ANTİKOR (IG G) | TEST | İnsan anti-fare antikor kiti | 200 |
| 38 | İMMÜNFLORESAN PRİMER ANTİKOR (IG M) | TEST | İnsan anti-fare antikor kiti | 200 |
| 39 | İMMÜNFLORESAN PRİMER ANTİKOR (KAPPA) | TEST | İnsan anti-fare antikor kiti | 300 |
| 40 | İMMÜNFLORESAN PRİMER ANTİKOR (LAMBDA) | TEST | İnsan anti-fare antikor kiti | 300 |
| 41 | İMMÜNFLORESAN PRİMER ANTİKOR (MYHC FAST) | TEST | İnsan anti-fare antikor kiti | 25 |
| 42 | İMMÜNFLORESAN PRİMER ANTİKOR (MYHC SLOW) | TEST | İnsan anti-fare antikor kiti | 25 |
| 43 | İMMÜNFLORESAN PRİMER ANTİKOR (? SARKOGLİKAN) | TEST | İnsan anti-fare antikor kiti | 25 |
| 44 | İMMÜNFLORESAN PRİMER ANTİKOR (ß SARKOGLİKAN) | TEST | İnsan anti-fare antikor kiti | 25 |
| 45 | İMMÜNFLORESAN PRİMER ANTİKOR ( ? SARKOGLİKAN) | TEST | İnsan anti-fare antikor kiti | 25 |
| 46 | İMMÜNOHİSTOKİMYASAL ANTİKOR (Muscle Specific Actin) | TEST | İnsan anti-fare antikor kiti | 200 |
| 47 | İMMÜNOHİSTOKİMYASAL ANTİKOR(Actin Smooth Muscle) | TEST | İnsan anti-fare antikor kiti | 300 |
| 48 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (ACTH) | TEST | İnsan anti-fare antikor kiti | 50 |
| 49 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (AFP) | TEST | İnsan anti-fare antikor kiti | 100 |
| 50 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (ALK) | TEST | İnsan anti-fare antikor kiti | 100 |
| 51 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (ALPHA 1-ANTİTRPYSİN) | TEST | İnsan anti-fare antikor kiti | 50 |
| 52 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (ALPHA METHYLACYL CoA RACEMASE) | TEST | İnsan anti-fare antikor kiti | 100 |
| 53 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (AMİYLOİD A) | TEST | İnsan anti-fare antikor kiti | 50 |
| 54 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (ANTI-HUMAN HEPATOCYTE) | TEST | İnsan anti-fare antikor kiti | 50 |
| 55 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (BAX) | TEST | İnsan anti-fare antikor kiti | 50 |
| 56 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (BCL-2) | TEST | İnsan anti-fare antikor kiti | 100 |
| 57 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (BCL-6) | TEST | İnsan anti-fare antikor kiti | 50 |
| 58 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (beta-HCG) | TEST | İnsan anti-fare antikor kiti | 50 |
| 59 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (C4d) | TEST | İnsan anti-fare antikor kiti | 100 |
| 60 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CALCİTONİN) | TEST | İnsan anti-fare antikor kiti | 100 |
| 61 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CALPONİN) | TEST | İnsan anti-fare antikor kiti | 100 |
| 62 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CALRETİNİN) | TEST | İnsan anti-fare antikor kiti | 100 |
| 63 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CAM5.2) | TEST | İnsan anti-fare antikor kiti | 50 |
| 64 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CATENİN BETA) | TEST | İnsan anti-fare antikor kiti | 100 |
| 65 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CAVEOLİN) | TEST | İnsan anti-fare antikor kiti | 25 |
| 66 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD10) | TEST | İnsan anti-fare antikor kiti | 100 |
| 67 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD117) | TEST | İnsan anti-fare antikor kiti | 200 |
| 68 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD13) | TEST | İnsan anti-fare antikor kiti | 50 |
| 69 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD138) | TEST | İnsan anti-fare antikor kiti | 100 |
| 70 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD14) | TEST | İnsan anti-fare antikor kiti | 50 |
| 71 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD141) | TEST | İnsan anti-fare antikor kiti | 50 |
| 72 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD15) | TEST | İnsan anti-fare antikor kiti | 200 |
| 73 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD19) | TEST | İnsan anti-fare antikor kiti | 50 |
| 74 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD1a) | TEST | İnsan anti-fare antikor kiti | 100 |
| 75 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD2) | TEST | İnsan anti-fare antikor kiti | 50 |
| 76 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD20) | TEST | İnsan anti-fare antikor kiti | 250 |
| 77 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD21) | TEST | İnsan anti-fare antikor kiti | 50 |
| 78 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD23) | TEST | İnsan anti-fare antikor kiti | 50 |
| 79 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD3) | TEST | İnsan anti-fare antikor kiti | 250 |
| 80 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD30) | TEST | İnsan anti-fare antikor kiti | 200 |
| 81 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD31) | TEST | İnsan anti-fare antikor kiti | 50 |
| 82 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD34) | TEST | İnsan anti-fare antikor kiti | 100 |
| 83 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD38) | TEST | İnsan anti-fare antikor kiti | 50 |
| 84 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD4) | TEST | İnsan anti-fare antikor kiti | 50 |
| 85 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD43) | TEST | İnsan anti-fare antikor kiti | 50 |
| 86 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD45 COCTAİL) | TEST | İnsan anti-fare antikor kiti | 250 |
| 87 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD45RO) | TEST | İnsan anti-fare antikor kiti | 200 |
| 88 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD5) | TEST | İnsan anti-fare antikor kiti | 50 |
| 89 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD56) | TEST | İnsan anti-fare antikor kiti | 100 |
| 90 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD57) | TEST | İnsan anti-fare antikor kiti | 100 |
| 91 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD61) | TEST | İnsan anti-fare antikor kiti | 50 |
| 92 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD68 PGM-1) | TEST | İnsan anti-fare antikor kiti | 50 |
| 93 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD68) | TEST | İnsan anti-fare antikor kiti | 50 |
| 94 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD79a) | TEST | İnsan anti-fare antikor kiti | 100 |
| 95 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD8) | TEST | İnsan anti-fare antikor kiti | 50 |
| 96 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CD99) | TEST | İnsan anti-fare antikor kiti | 100 |
| 97 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CDX2) | TEST | İnsan anti-fare antikor kiti | 50 |
| 98 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CEA) (MONOKLONAL) | TEST | İnsan anti-fare antikor kiti | 100 |
| 99 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CEA) (POLYKLONAL) | TEST | İnsan anti-fare antikor kiti | 100 |
| 100 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (Cerb B2) | TEST | İnsan anti-fare antikor kiti | 200 |
| 101 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CHROMAGRANİN A) | TEST | İnsan anti-fare antikor kiti | 100 |
| 102 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CMV) | TEST | İnsan anti-fare antikor kiti | 50 |
| 103 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (COLLAGEN IV) | TEST | İnsan anti-fare antikor kiti | 50 |
| 104 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (COX2) | TEST | İnsan anti-fare antikor kiti | 50 |
| 105 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (CYCLİN D1) | TEST | İnsan anti-fare antikor kiti | 100 |
| 106 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (D2-40) | TEST | İnsan anti-fare antikor kiti | 100 |
| 107 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (DESMİN) | TEST | İnsan anti-fare antikor kiti | 150 |
| 108 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (EBV) | TEST | İnsan anti-fare antikor kiti | 50 |
| 109 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (E-CADHERİN) | TEST | İnsan anti-fare antikor kiti | 100 |
| 110 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (EGFR) | TEST | İnsan anti-fare antikor kiti | 50 |
| 111 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (EMA) | TEST | İnsan anti-fare antikor kiti | 100 |
| 112 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (ESTROGEN) | TEST | İnsan anti-fare antikor kiti | 250 |
| 113 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (FAKTÖR VIII) | TEST | İnsan anti-fare antikor kiti | 50 |
| 114 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (FAKTÖR XIIIa) | TEST | İnsan anti-fare antikor kiti | 50 |
| 115 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (FASCİN) | TEST | İnsan anti-fare antikor kiti | 50 |
| 116 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (FSH) | TEST | İnsan anti-fare antikor kiti | 50 |
| 117 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (GALECTİN 3) | TEST | İnsan anti-fare antikor kiti | 50 |
| 118 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (GASTRİN) | TEST | İnsan anti-fare antikor kiti | 50 |
| 119 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (GCDFP-15) | TEST | İnsan anti-fare antikor kiti | 50 |
| 120 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (GFAP) | TEST | İnsan anti-fare antikor kiti | 50 |
| 121 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (GH) | TEST | İnsan anti-fare antikor kiti | 50 |
| 122 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (GLYCOPHORİN A) | TEST | İnsan anti-fare antikor kiti | 50 |
| 123 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (GRANZYME B) | TEST | İnsan anti-fare antikor kiti | 50 |
| 124 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (H PYLORİ) | TEST | İnsan anti-fare antikor kiti | 50 |
| 125 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (HBcAG) | TEST | İnsan anti-fare antikor kiti | 50 |
| 126 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (HBsAG) | TEST | İnsan anti-fare antikor kiti | 50 |
| 127 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (HEPATİTİS C VİRÜS) | TEST | İnsan anti-fare antikor kiti | 50 |
| 128 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (HHV8) | TEST | İnsan anti-fare antikor kiti | 50 |
| 129 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (HLA-DR) | TEST | İnsan anti-fare antikor kiti | 50 |
| 130 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (HPV PAN) | TEST | İnsan anti-fare antikor kiti | 75 |
| 131 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (HSV) | TEST | İnsan anti-fare antikor kiti | 50 |
| 132 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (IG A) | TEST | İnsan anti-fare antikor kiti | 100 |
| 133 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (IG D) | TEST | İnsan anti-fare antikor kiti | 100 |
| 134 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (IG G) | TEST | İnsan anti-fare antikor kiti | 100 |
| 135 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (IG M) | TEST | İnsan anti-fare antikor kiti | 100 |
| 136 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (İNHİBİN ALPHA) | TEST | İnsan anti-fare antikor kiti | 50 |
| 137 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (İNSULİN) | TEST | İnsan anti-fare antikor kiti | 50 |
| 138 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (KAPPA) | TEST | İnsan anti-fare antikor kiti | 100 |
| 139 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (KERATIN HMW 34bE12) | TEST | İnsan anti-fare antikor kiti | 100 |
| 140 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (KERATİN PAN) | TEST | İnsan anti-fare antikor kiti | 250 |
| 141 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (KERATİN19) | TEST | İnsan anti-fare antikor kiti | 50 |
| 142 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (KERATİN20) | TEST | İnsan anti-fare antikor kiti | 100 |
| 143 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (KERATİN5/6) | TEST | İnsan anti-fare antikor kiti | 75 |
| 144 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (KERATİN7) | TEST | İnsan anti-fare antikor kiti | 100 |
| 145 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (Kİ67) | TEST | İnsan anti-fare antikor kiti | 200 |
| 146 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (LH) | TEST | İnsan anti-fare antikor kiti | 50 |
| 147 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (MART 1) | TEST | İnsan anti-fare antikor kiti | 75 |
| 148 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (MELANOMA HMB45) | TEST | İnsan anti-fare antikor kiti | 75 |
| 149 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (MESOTHELİOMA) | TEST | İnsan anti-fare antikor kiti | 100 |
| 150 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (MİTOCHONDRİA) | TEST | İnsan anti-fare antikor kiti | 50 |
| 151 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (MLH1) | TEST | İnsan anti-fare antikor kiti | 75 |
| 152 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (MOC31) | TEST | İnsan anti-fare antikor kiti | 100 |
| 153 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (MSH2) | TEST | İnsan anti-fare antikor kiti | 75 |
| 154 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (MSH6) | TEST | İnsan anti-fare antikor kiti | 75 |
| 155 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (MUC 2) | TEST | İnsan anti-fare antikor kiti | 50 |
| 156 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (MUC5AC) | TEST | İnsan anti-fare antikor kiti | 50 |
| 157 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (MUM 1) | TEST | İnsan anti-fare antikor kiti | 50 |
| 158 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (MYELOPEROXİDASE) | TEST | İnsan anti-fare antikor kiti | 100 |
| 159 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (MYO D1) | TEST | İnsan anti-fare antikor kiti | 75 |
| 160 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (MYOSİN SK MUSCLE) | TEST | İnsan anti-fare antikor kiti | 50 |
| 161 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (NAPSİN A) | TEST | İnsan anti-fare antikor kiti | 75 |
| 162 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (NEUROFİLAMENT) | TEST | İnsan anti-fare antikor kiti | 75 |
| 163 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (NSE) | TEST | İnsan anti-fare antikor kiti | 75 |
| 164 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (P53) | TEST | İnsan anti-fare antikor kiti | 75 |
| 165 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (P57) | TEST | İnsan anti-fare antikor kiti | 75 |
| 166 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (P63) | TEST | İnsan anti-fare antikor kiti | 75 |
| 167 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (PLAP) | TEST | İnsan anti-fare antikor kiti | 50 |
| 168 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (PLASMA CELL) | TEST | İnsan anti-fare antikor kiti | 50 |
| 169 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (PMS2) | TEST | İnsan anti-fare antikor kiti | 50 |
| 170 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (PNEUMOCYSTİS JİROVECİİ) | TEST | İnsan anti-fare antikor kiti | 100 |
| 171 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (PROCOLLEGEN) | TEST | İnsan anti-fare antikor kiti | 50 |
| 172 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (PROGESTERON RESEPTÖRÜ) | TEST | İnsan anti-fare antikor kiti | 250 |
| 173 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (PROLACTİN) | TEST | İnsan anti-fare antikor kiti | 50 |
| 174 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (PSA) | TEST | İnsan anti-fare antikor kiti | 50 |
| 175 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (PTEN) | TEST | İnsan anti-fare antikor kiti | 50 |
| 176 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (PTH) | TEST | İnsan anti-fare antikor kiti | 50 |
| 177 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (RENALL CELL) | TEST | İnsan anti-fare antikor kiti | 100 |
| 178 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (S-100) | TEST | İnsan anti-fare antikor kiti | 100 |
| 179 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (SOMATOSTATİN) | TEST | İnsan anti-fare antikor kiti | 50 |
| 180 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (SURVİVİN) | TEST | İnsan anti-fare antikor kiti | 50 |
| 181 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (SYNAPTOPHYSİN) | TEST | İnsan anti-fare antikor kiti | 100 |
| 182 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (TdT) | TEST | İnsan anti-fare antikor kiti | 75 |
| 183 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (TFE3) | TEST | İnsan anti-fare antikor kiti | 50 |
| 184 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (THYROGLOBULİN) | TEST | İnsan anti-fare antikor kiti | 50 |
| 185 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (TIA1) | TEST | İnsan anti-fare antikor kiti | 50 |
| 186 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (TRAP) | TEST | İnsan anti-fare antikor kiti | 50 |
| 187 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (TSH) | TEST | İnsan anti-fare antikor kiti | 50 |
| 188 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (TTF-1) | TEST | İnsan anti-fare antikor kiti | 75 |
| 189 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (ÜROPLAKİN) | TEST | İnsan anti-fare antikor kiti | 50 |
| 190 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (VİMENTİN) | TEST | İnsan anti-fare antikor kiti | 200 |
| 191 | İMMÜNOHİSTOKİMYASAL PRİMER ANTİKOR (WİLM'S TÜMÖR) | TEST | İnsan anti-fare antikor kiti | 100 |
| 192 | İODİNE | GRAM | YARDIMCI SARF MALZEMELER | 500 |
| 193 | KSİLEN | LİTRE | YARDIMCI SARF MALZEMELER | 500 |
| 194 | LAM (RENKLİ UÇLU TİP) | ADET | Lam, mikroskop | 200.000 |
| 195 | LAM (YAPIŞKANLI TİP) | ADET | Lam, mikroskop | 75.000 |
| 196 | LAM LAMEL YAPIŞTIRICISI | LİTRE | Lam, mikroskop | 30 |
| 197 | LAMEL 24X50 | ADET | Lam, mikroskop | 350.000 |
| 198 | MAPE PLASTİK (20 LAMLIK) | ADET | Lam kurutucusu | 50 |
| 199 | MAY GRUNWALD SOLÜSYONU | LİTRE | SOLÜSYONLAR, "Belirtin" | 5 |
| 200 | METANİL YELLOW | GRAM | YARDIMCI SARF MALZEMELER | 50 |
| 201 | METHANOL | LİTRE | SOLÜSYONLAR, "Belirtin" | 2 |
| 202 | METHİLEN BLUE | GRAM | SOLÜSYONLAR, "Belirtin" | 12 |
| 203 | MİKROTOM BIÇAĞI DİSPOSABLE | ADET | Kesici, mikrotom, tek kullanımlık | 7.500 |
| 204 | NİTROBLUE TETRAZOLİUM BLUE CHLORİDE | GRAM | YARDIMCI SARF MALZEMELER | 10 |
| 205 | OİL RED O | GRAM | SOLÜSYONLAR, "Belirtin" | 25 |
| 206 | ORANGE G | LİTRE | SOLÜSYONLAR, "Belirtin" | 60 |
| 207 | ORCEİN | GRAM | SOLÜSYONLAR, "Belirtin" | 2 |
| 208 | PARAFİN | KİLO | YARDIMCI SARF MALZEMELER | 250 |
| 209 | PHENOL (SIVI) | LİTRE | YARDIMCI SARF MALZEMELER | 1 |
| 210 | PROPYLENE GLİKOL | LİTRE | YARDIMCI SARF MALZEMELER | 2 |
| 211 | PYRONİN | LİTRE | YARDIMCI SARF MALZEMELER | 5 |
| 212 | PYRONİN GS | GRAM | YARDIMCI SARF MALZEMELER | 12 |
| 213 | RHODAMİNE B | GRAM | YARDIMCI SARF MALZEMELER | 5 |
| 214 | RHODANİNE | GRAM | YARDIMCI SARF MALZEMELER | 25 |
| 215 | RUBEANİC ACİD | GRAM | SOLÜSYONLAR, "Belirtin" | 5 |
| 216 | SCHİFF'S REAGENT | LİTRE | SOLÜSYONLAR, "Belirtin" | 2 |
| 217 | SODYUM CHLORÜR | KİLO | YARDIMCI SARF MALZEMELER | 5 |
| 218 | SODYUM FOSFAT DİBAZİK ANHİDRİ | GRAM | YARDIMCI SARF MALZEMELER | 5.000 |
| 219 | SODYUM FOSFAT MONOBAZİK | GRAM | YARDIMCI SARF MALZEMELER | 5.000 |
| 220 | SODYUM METABİSÜLFİTE | GRAM | YARDIMCI SARF MALZEMELER | 2 |
| 221 | SODYUM SUKSİNAT | GRAM | YARDIMCI SARF MALZEMELER | 25 |
| 222 | SUCROSE | GRAM | YARDIMCI SARF MALZEMELER | 100 |
| 223 | TOLUİDİNE BLUE | GRAM | YARDIMCI SARF MALZEMELER | 2 |
| 224 | TRİCHLORACETİK ACİD | GRAM | YARDIMCI SARF MALZEMELER | 5 |